Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia

International Journal of Laboratory Hematology

Volumn 34, Issue 1, 2012, Pages

  Koldehoff, M ^a   Steckel, N K ^a   Hegerfeldt, Y ^a   Ditschkowski, M ^a   Beelen, D W ^a   Elmaagacli, A H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAGRELIDE; BCR ABL PROTEIN; BUSULFAN; HEMOGLOBIN; HYDROXYUREA; INTERFERON; JANUS KINASE 2; PROTEIN TYROSINE KINASE;

ACUTE LEUKEMIA; ADULT; ANEMIA; ATYPICAL CHRONIC MYELOID LEUKEMIA; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSERYTHROPOIESIS; FEMALE; GENE MUTATION; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HEPATOSPLENOMEGALY; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MOLECULAR PATHOLOGY; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; OVERALL SURVIVAL; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTOSIS; ULTRASOUND;

ADULT; EXONS; FEMALE; HUMANS; JANUS KINASE 2; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC, ATYPICAL, BCR-ABL NEGATIVE; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 84155186675     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01351.x     Document Type: Letter

References (12)

1. Fend F, Horn T, Koch I, Vela T & Orazi A. (2008) Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm. Leukemia Research 32, 1931-1935.
2. Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C, Kreil S, Jones A, Score J, Metzgeroth G, Oscier D, Hall A, Brandts C, Serve H, Reiter A, Chase AJ & Cross NC. (2009) Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 113, 6182-6192.
3. Hernández JM, del Cañizo MC, Cuneo A, García JL, Gutiérrez NC, González M, Castoldi G & San Miguel JF. (2000) Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Annals of Oncology 11, 441-444.
4. Jones AV, Cross NC, White HE, Green AR & Scott LM. (2008) Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis. Haematologica 93, 1560-1564.
5. Koldehoff M, Beelen DW, Trenschel R, Steckel NK, Peceny R, Ditschkowski M, Ottinger H & Elmaagacli AH. (2004) Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia. Bone Marrow Transplantation 34, 1047-1050.
6. Onida F, Ball G, Kantarjian HM, Smith TL, Glassman A, Albitar M, Scappini B, Rios MB, Keating MJ & Beran M. (2002) Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia. Cancer 95, 1673-1684.
7. Oscier DG. (1996) Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome. British Journal of Haematology 92, 582-586.
8. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, Steensma DP, Elliott MA, Wolanskyj AP, Hogan WJ, McClure RF, Litzow MR, Gilliland DG & Tefferi A (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 108: 3472-3476.
9. Steckel NK, Koldehoff M, Ditschkowski M, Beelen DW & Elmaagacli AH. (2007) Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis with myeloid metaplasia after allogeneic stem cell transplantation. Transplantation 83, 1518-1520.
10. Tefferi A & Vardiman JW. (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22, 14-22.
11. Vardiman JW, Bennet JM, Bain B, Brunning RD & Thiele J. (2008) Atypical chronic myeloid leukaemia, BCR-ABL1 negative. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman ), 80-81. IARC Press, Lyon.
12. Xubo G, Xingguo L, Xianguo W, Rongzhen X, Xibin X, Lin W, Lei Z, Xiaohong Z, Genbo X & Xiaoying Z. (2009) The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia. European Journal of Haematology 83, 292-301.